Andrea Marshall
Overview
Explore the profile of Andrea Marshall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
2510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dunn J, Donnelly P, Elbeltagi N, Marshall A, Hopkins A, Thompson A, et al.
Lancet
. 2025 Feb;
405(10476):396-407.
PMID: 39892911
Background: The frequency of mammographic surveillance for women after diagnosis of breast cancer varies globally. The aim of this study was to evaluate whether less than annual mammography was non-inferior...
2.
Lanting V, Takada T, Bosch F, Marshall A, Grosso M, Young A, et al.
Thromb Haemost
. 2024 Sep;
PMID: 39299270
Background: About 7% of patients with cancer-associated venous thromboembolism (CAT) develop a recurrence during anticoagulant treatment. Identification of high-risk patients may help guide treatment decisions. Aim: To identify clinical predictors...
3.
Samani N, Beeston E, Greengrass C, Riveros-Mckay F, Debiec R, Lawday D, et al.
Eur Heart J
. 2024 Jun;
45(34):3152-3160.
PMID: 38848106
Background And Aims: A cardiovascular disease polygenic risk score (CVD-PRS) can stratify individuals into different categories of cardiovascular risk, but whether the addition of a CVD-PRS to clinical risk scores...
4.
Jones L, Marshall A, Geach R, Elangovan P, OFlynn E, Timlin T, et al.
Breast Cancer Res
. 2024 May;
26(1):85.
PMID: 38807211
Background: Abbreviated breast MRI (FAST MRI) is being introduced into clinical practice to screen women with mammographically dense breasts or with a personal history of breast cancer. This study aimed...
5.
Goetze J, Heithaus M, MacNeil M, Harvey E, Simpfendorfer C, Heupel M, et al.
Nat Ecol Evol
. 2024 May;
8(6):1118-1128.
PMID: 38769434
Many shark populations are in decline around the world, with severe ecological and economic consequences. Fisheries management and marine protected areas (MPAs) have both been heralded as solutions. However, the...
6.
Balhara M, Neikirk K, Marshall A, Hinton Jr A, Kirabo A
Curr Hypertens Rep
. 2024 Apr;
26(6):273-290.
PMID: 38602583
Purpose Of Review: Hypertension is a principal risk factor for cardiovascular morbidity and mortality, with its severity exacerbated by high sodium intake, particularly in individuals with salt-sensitive blood pressure. However,...
7.
Lee H, Bates A, Callier S, Chan M, Chambwe N, Marshall A, et al.
JAMA Oncol
. 2024 Mar;
10(5):652-657.
PMID: 38512297
Importance: Racially minoritized and socioeconomically disadvantaged populations are currently underrepresented in clinical trials. Data-driven, quantitative analyses and strategies are required to help address this inequity. Objective: To systematically analyze the...
8.
Hinton Jr A, Katti P, Mungai M, Hall D, Koval O, Shao J, et al.
J Cell Physiol
. 2024 Feb;
239(4):e31204.
PMID: 38419397
Mitochondria and endoplasmic reticulum (ER) contact sites (MERCs) are protein- and lipid-enriched hubs that mediate interorganellar communication by contributing to the dynamic transfer of Ca, lipid, and other metabolites between...
9.
Cignarella A, Marshall A, Ranse K, Opdam H, Buckley T, Hewitt J
J Bioeth Inq
. 2023 Dec;
21(2):309-329.
PMID: 38060147
Introduction: The disclosure of information that identifies deceased organ donors and/or organ transplant recipients by organ donation agencies and transplant centres is regulated in Australia by state and territory legislation,...
10.
van Hylckama Vlieg M, Nasserinejad K, Visser C, Bramer W, Ashrani A, Bosson J, et al.
EClinicalMedicine
. 2023 Sep;
64:102194.
PMID: 37731937
Background: The optimal duration of anticoagulation in patients with active cancer and venous thromboembolism (VTE) is unknown. Current clinical guidelines advocate anticoagulant therapy for 3-6 months and to continue anticoagulant...